'Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Allotment of Equity Shares under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan, 2022
JAGSNPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jagsonpal Pharmaceuticals has allotted 35,000 equity shares of face value Rs. 2 each to eligible employees under the Jagsonpal Pharmaceuticals Limited Employee Stock Option Plan (JPL ESOP 2022). The shares were issued at an exercise price of Rs. 94 per share, which includes a premium of Rs. 92 per share. As a result, the company's paid-up share capital has risen from Rs. 13,28,76,960 (6,64,38,480 shares) to Rs. 13,29,46,960 (6,64,73,480 shares). The newly allotted shares will carry equal rights as existing equity shares. The original ESOP plan was filed with stock exchanges in July 2022.
This is a routine ESOP allotment with a very small dilution of about 0.005% to existing shareholders. Negligible impact on shareholding or stock price; no immediate action needed for retail investors.